Thorne HealthTech Future Growth
Future criteria checks 4/6
Thorne HealthTech is forecast to grow earnings and revenue by 57.2% and 19.8% per annum respectively while EPS is expected to grow by 56.6% per annum.
Key information
57.2%
Earnings growth rate
56.6%
EPS growth rate
Personal Products earnings growth | 26.1% |
Revenue growth rate | 19.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Oct 2023 |
Recent future growth updates
Recent updates
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Aug 12Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar
Jun 07Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist
Dec 17Thorne HealthTech Grows But Faces Macro Headwinds
Sep 09Thorne HealthTech's blood collection device OneDraw gets clearance in Japan
Aug 23Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised
Aug 09Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies
Jun 05Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality
Mar 23Thorne HealthTech: Good Potential At A Low Price
Jan 11Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 418 | 68 | 65 | 72 | 2 |
12/31/2024 | 363 | 34 | 61 | 68 | 3 |
12/31/2023 | 288 | 16 | 17 | 47 | 2 |
6/30/2023 | 258 | 20 | -15 | 22 | N/A |
3/31/2023 | 240 | 10 | -25 | 4 | N/A |
12/31/2022 | 229 | 16 | -13 | 5 | N/A |
9/30/2022 | 216 | 6 | -14 | -6 | N/A |
6/30/2022 | 206 | 3 | -5 | 1 | N/A |
3/31/2022 | 194 | 9 | -11 | -4 | N/A |
12/31/2021 | 184 | 4 | 4 | 9 | N/A |
9/30/2021 | 172 | -1 | 8 | 12 | N/A |
6/30/2021 | 162 | -1 | 9 | 12 | N/A |
3/31/2021 | 150 | -3 | 20 | 23 | N/A |
12/31/2020 | 138 | -3 | 15 | 17 | N/A |
12/31/2019 | 103 | -22 | -11 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: THRN's forecast earnings growth (57.2% per year) is above the savings rate (2.2%).
Earnings vs Market: THRN's earnings (57.2% per year) are forecast to grow faster than the US market (14.9% per year).
High Growth Earnings: THRN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: THRN's revenue (19.8% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: THRN's revenue (19.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if THRN's Return on Equity is forecast to be high in 3 years time